US Broker Ratings

Ascentage Pharma Group Internat (AAPG): Investor Outlook on a Biotech Pioneer with 78.64% Potential Upside

Ascentage Pharma Group Internat (AAPG), a clinical-stage biotechnology company based in Suzhou, China, is carving a significant niche in the healthcare sector with its innovative therapies targeting cancers, chronic hepatitis..

Artivion, Inc. (AORT) Stock Analysis: A 20% Upside Potential in the Medical Devices Sector

Artivion, Inc. (NASDAQ: AORT), a prominent player in the medical devices industry, has been capturing the attention of investors with its significant upside potential, driven by innovative products and strategic..

Azenta, Inc. (AZTA) Stock Analysis: Exploring a 9% Potential Upside in the Healthcare Sector

Investors with an eye on the healthcare sector may want to take a closer look at Azenta, Inc. (NASDAQ: AZTA), a company that specializes in providing innovative solutions for biological..

SS Innovations International (SSII) Stock Analysis: Navigating the Robotic Revolution with 192.5% Revenue Growth

Investors looking for exposure in the burgeoning field of surgical robotics should pay close attention to SS Innovations International, Inc. (SSII). Headquartered in Gurugram, India, this healthcare company is making..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Exploring a 52.51% Potential Upside in Biotech

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) presents an intriguing opportunity for investors looking to delve into the biotechnology sector. This clinical-stage company, headquartered in Salt Lake City, Utah, is pioneering the..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Uncovering a 53.98% Potential Upside in Biotech

Investors keen on the biotechnology sector should take a closer look at Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a promising player in the healthcare industry. With a market capitalization of $2.61..

ICU Medical, Inc. (ICUI) Stock Analysis: A Potential 18.3% Upside with Strong Buy Ratings

ICU Medical, Inc. (NASDAQ: ICUI) presents a compelling investment case for those eyeing the healthcare sector, particularly in the medical instruments and supplies industry. As a United States-based company with..

Clover Health Investments, Corp (CLOV) Stock Analysis: Exploring a 29.85% Potential Upside in Healthcare Plans

Clover Health Investments, Corp (NASDAQ: CLOV), a prominent player in the healthcare plans sector, offers a unique investment opportunity, especially for those seeking exposure to the burgeoning Medicare Advantage market...

BioLife Solutions, Inc. (BLFS): Investor Outlook Highlights 30% Potential Upside with Strong Buy Ratings

BioLife Solutions, Inc. (NASDAQ: BLFS), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, offers a compelling investment opportunity for those interested in the..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Unveiling a 14% Upside Potential in Healthcare

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN), a key player in the medical care facilities industry with a market capitalization of $1.94 billion, has caught the attention of investors with its..

10x Genomics, Inc. (TXG) Stock Analysis: A Cautious Investor Outlook Amidst Negative Revenue Growth

10x Genomics, Inc. (TXG) is a prominent player in the healthcare sector, specifically within the Health Information Services industry. Headquartered in Pleasanton, California, the company has carved a niche in..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Biotechnology Innovator with 122% Upside Potential

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is capturing investor attention thanks to its innovative approach in the biotechnology sector and a remarkable potential upside of 122.68%. As a biopharmaceutical company based..

HUTCHMED (China) Limited (HCM) Stock Analysis: Uncovering a 35.50% Potential Upside Amid Mixed Financial Signals

HUTCHMED (China) Limited, trading under the ticker symbol HCM, stands as a notable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Hong..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 22.79% Potential Upside

U.S. Physical Therapy, Inc. (NYSE: USPH) is capturing investor attention with its robust growth potential and strong market presence in the healthcare sector. Known for managing outpatient physical therapy clinics..

Vericel Corporation (VCEL) Stock Analysis: Healthcare Innovator with 45.89% Upside Potential

Vericel Corporation (NASDAQ: VCEL), a key player in the biotechnology sector, has become a focus of attention for investors eyeing the healthcare market. With a market capitalization of $1.91 billion,..

Viridian Therapeutics, Inc. (VRDN) Investor Outlook: Strong Buy Ratings and 26.51% Potential Upside

Viridian Therapeutics, Inc. (NASDAQ: VRDN) is making waves in the biotechnology sector with its aggressive push towards innovative treatments for serious and rare diseases. With a market capitalization of $3.16..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Unveiling a 117% Potential Upside in Biotechnology

Dyne Therapeutics, Inc. (NASDAQ: DYN) is catching the attention of investors, particularly those with a keen eye on the biotechnology sector. With a robust market capitalization of $2.96 billion, this..

LifeStance Health Group, Inc. (LFST) Investor Outlook: Analyzing a 21.6% Potential Upside with Strong Buy Ratings

LifeStance Health Group, Inc. (NASDAQ: LFST) is making waves in the healthcare sector, particularly within the medical care facilities industry. Headquartered in Scottsdale, Arizona, LifeStance provides a comprehensive suite of..

Mesoblast Limited (MESO) Stock Analysis: Exploring an 87% Upside Potential for Investors

Mesoblast Limited (MESO), a biotechnology company based in Australia, is carving a niche in the healthcare sector with its innovative regenerative medicine products. With a market capitalization of $2.48 billion,..

Surgery Partners, Inc. (SGRY) Stock Analysis: Healthcare Growth with a 57% Potential Upside

Surgery Partners, Inc. (NASDAQ: SGRY) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. With a robust market capitalization of $2.1 billion, this Brentwood,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds